Hospira Recalls Lidocaine Hydrochloride Injection Due to Particulate Matter
Hospira, Inc. is recalling Lidocaine Hydrochloride Injection vials because iron oxide particulate matter was found embedded in the glass vial necks.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the presence of particulate matter in an injectable drug represents a risk-of-harm product where injury has not yet been reported.
Plain-English summary
Hospira, Inc. is recalling 100,200 vials of 1% Lidocaine Hydrochloride Injection, USP. The affected product is a single-dose, preservative-free 30 mL vial (NDC 0409-4279-02) distributed nationwide. The specific lot number is 44-359-DK, with an expiration date of 08/01/2016.
The recall was initiated because particulate matter, identified as iron oxide, was found embedded in the neck of the glass vials. This physical defect presents a risk of introducing foreign material into the patient during administration.
Healthcare providers and patients should discontinue use of the affected vials. The product is a prescription-only medication intended for infiltration or perineural routes. Users should check their inventory for the specific lot number and expiration date listed above.
The recalled product
- Product
- LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
- Brand
- LIDOCAINE HYDROCHLORIDE
- Manufacturer
- Hospira, Inc.
- Category
- Drug — Injectable
- Affected units
- 100,200
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 44-359-DK
- Exp 08/01/2016
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LIDOCAINE HYDROCHLORIDE
- SevereLidocaine Hydrochloride Injection Recalled for Sterility Assurance
FDA (Drugs) · 2026-07-08
- HighSpectra lidocaine ampules recalled over lack of sterility assurance
FDA (Drugs) · 2026-06-10
- HighHuons lidocaine injection recalled nationwide over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- HighHuons lidocaine 2% injection recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- SevereLidocaine injection recalled due to glass particulate matter
FDA (Drugs) · 2023-11-15
Same manufacturer · Hospira, Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26